InsiderTrades.com logo

LGVN Insider Trading

Insider Ownership Percentage: 7.42%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00

Longeveron Insider Trading History Chart

This chart shows the insider buying and selling history at Longeveron by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Longeveron Share Price & Price History

Current Price: $2.37
Price Change: ▼ Price Decrease of -0.07 (-2.87%)
As of 10/8/2026 04:00 PM ET

This chart shows the closing price history over time for LGVN up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Longeveron Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/30/2025Rock SofferDirectorSell1,100$12.50$13,750.0020,903View SEC Filing Icon  
5/29/2025Rock SofferDirectorSell1,000$13.00$13,000.0022,003View SEC Filing Icon  
5/22/2025Rock SofferDirectorSell200$13.20$2,640.0023,003View SEC Filing Icon  
5/16/2025Joshua HareInsiderSell525$14.00$7,350.0072,179View SEC Filing Icon  
12/2/2024Khoso BaluchDirectorSell125$20.70$2,587.502,375View SEC Filing Icon  
4/11/2024Mohamed Wa'el Ahmed HashadCEOBuy1,063$23.50$24,980.501,961View SEC Filing Icon  
4/11/2024Rock SofferDirectorBuy3,191$23.50$74,988.5020,853View SEC Filing Icon  
4/10/2024Joshua HareInsiderBuy10,638$23.50$249,993.0059,072View SEC Filing Icon  
1/10/2024Cathy RossDirectorBuy50$131.00$6,550.00100View SEC Filing Icon  
12/28/2023Jeffrey PfefferDirectorBuy100$135.00$13,500.00150View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Longeveron (NASDAQ:LGVN)

10.01% of Longeveron stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at LGVN by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Longeveron Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/18/2026ADAR1 Capital Management LLC200,000$0.21M0.0%N/A0.859%Search for SEC Filing on Google Icon
8/12/2025XTX Topco Ltd48,003$62K0.0%N/A0.316%Search for SEC Filing on Google Icon
5/9/2025R Squared Ltd24,560$38K0.0%+160.7%0.165%Search for SEC Filing on Google Icon
2/14/2025Jane Street Group LLC20,493$35K0.0%N/A0.138%Search for SEC Filing on Google Icon
2/14/2025Northern Trust Corp18,190$31K0.0%N/A0.123%Search for SEC Filing on Google Icon
2/11/2025Virtu Financial LLC30,402$53K0.0%N/A0.205%Search for SEC Filing on Google Icon
11/16/2024Geode Capital Management LLC128,947$0.25M0.0%+316.0%0.898%Search for SEC Filing on Google Icon
11/15/2024State Street Corp15,180$29K0.0%N/A0.106%Search for SEC Filing on Google Icon
8/9/2024Renaissance Technologies LLC146,700$0.24M0.0%N/A2.311%Search for SEC Filing on Google Icon
2/13/2024Armistice Capital LLC1,836,000$2.50M0.0%N/A7.312%Search for SEC Filing on Google Icon
7/21/2023Creative Planning109,322$0.37M0.0%N/A0.519%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Longeveron logo
Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions in the United States and Japan. The company's lead investigational product is the LOMECEL-B, an allogeneic mesenchymal stem cell formulation sourced from the bone marrow of young and healthy adult donors. It is conducting Phase 1, Phase 1/2, Phase 2a, and Phase 2b clinical trials in various indications, such as aging-related frailty, alzheimer's disease, and hypoplastic left heart syndrome. Longeveron Inc. was incorporated in 2014 and is headquartered in Miami, Florida.
Read More on Longeveron

Today's Range

Now: $2.37
Low: $2.32
High: $2.57

50 Day Range

MA: $5.74
Low: $2.35
High: $8.45

52 Week Range

Now: $2.37
Low: $2.30
High: $12.30

Volume

77,153 shs

Average Volume

185,215 shs

Market Capitalization

$7.56 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Longeveron?

Longeveron's top insider shareholders include:
  1. Joshua Hare (Insider)
  2. Rock Soffer (Director)
  3. Khoso Baluch (Director)
  4. Mohamed Wa'el Ahmed Hashad (CEO)
  5. James Clavijo (CFO)
  6. Jeffrey Pfeffer (Director)
  7. Cathy Ross (Director)
  8. Geoff Green (CEO)
  9. Paul T Lehr (General Counsel)
Learn More about top insider investors at Longeveron.

Longeveron Active Insiders

Geoff Green
Geoff Green (Age 51)
CEO
James Clavijo
James Clavijo (Age 58)
CFO
Rock Soffer
Rock Soffer
Director
Paul T Lehr
Paul T Lehr (Age 57)
General Counsel
Joshua Hare
Joshua Hare (Age 62)
Insider